Hazel Winchester

Head of Investor Relations at Cosmo Pharmaceuticals

Swiss Canadian (born 1971) Head of Investor Relations (IR). Ms. Winchester joined Cosmo in January 2022. She began her IR career in Canada where she held various IR positions for international companies communicating with the media, buying and sell-side analysts, and being responsible for stakeholder engagement. Her previously held positions were with a Swiss Medtech and more recently with a SIX-listed biopharmaceutical company. Prior to that, Ms. Winchester worked for a Canadian company that grew from a small to a large-cap multi-billion dollar company listed on the Toronto Stock Exchange (TSE) and New York Stock Exchange (NYSE). She has served on the board of the Canadian Investor Relations Institute (CIRI) and is now a board member of IR Club Switzerland.

Org chart

Peers

Timeline

  • Head of Investor Relations

    Current role

View in org chart